CStone Pharmaceuticals (CSPHF)

CStone Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 6, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,043	378	371	708	1,235	1,496
Market Cap Growth	167.41%	1.99%	-47.65%	-42.68%	-17.43%	11.69%
Enterprise Value	1,002	306	259	539	853	1,182
Last Close Price	0.70	0.23	0.32	0.59	1.24	1.13
PS Ratio	36.92	6.78	5.67	10.14	32.19	9.40
PB Ratio	23.73	7.58	5.75	10.87	6.50	3.31
P/TBV Ratio	46.86	13.62	9.26	16.86	6.90	3.31
EV/Sales Ratio	35.29	5.48	3.95	7.73	22.22	7.43
Debt / Equity Ratio	1.24	0.98	0.80	0.64	0.14	0.03
Net Debt / Equity Ratio	-0.95	-1.00	-1.50	-1.92	-1.33	-1.18
Net Debt / EBITDA Ratio	0.84	4.43	1.22	0.96	0.88	3.21
Net Debt / FCF Ratio	0.69	1.06	1.16	1.41	1.02	6.06
Asset Turnover	0.15	0.27	0.28	0.25	0.08	0.31
Inventory Turnover	1.38	0.85	2.44	4.86	-	-
Quick Ratio	1.20	1.18	1.44	1.29	2.03	4.91
Current Ratio	1.44	1.60	1.56	1.32	2.10	4.91
Return on Equity (ROE)	-96.36%	-22.23%	-81.05%	-109.00%	-92.28%	-44.92%
Return on Assets (ROA)	-16.93%	-3.90%	-21.93%	-29.16%	-37.90%	-20.33%
Return on Capital Employed (ROCE)	-65.20%	-13.40%	-71.40%	-131.80%	-136.70%	-36.00%
Earnings Yield	-5.04%	-3.31%	-13.98%	-18.49%	-24.47%	-12.50%
FCF Yield	-	-12.44%	-22.41%	-12.51%	-20.08%	-5.89%
Buyback Yield / Dilution	-1.61%	-1.04%	-7.69%	-0.66%	-11.39%	-20.69%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.